352 related articles for article (PubMed ID: 28365181)
1. Sudden death in ischemic heart disease - 2017.
Buxton AE
Int J Cardiol; 2017 Jun; 237():64-66. PubMed ID: 28365181
[TBL] [Abstract][Full Text] [Related]
2. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
Hilleman DE; Bauman AL
Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
[TBL] [Abstract][Full Text] [Related]
3. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society.
Silka MJ; Kron J; Dunnigan A; Dick M
Circulation; 1993 Mar; 87(3):800-7. PubMed ID: 8443901
[TBL] [Abstract][Full Text] [Related]
4. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
[TBL] [Abstract][Full Text] [Related]
5. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction.
Waks JW; Buxton AE
Annu Rev Med; 2018 Jan; 69():147-164. PubMed ID: 29414264
[TBL] [Abstract][Full Text] [Related]
6. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
7. [Antiarrhythmic therapy in patients with heart failure].
Faber TS; Zehender M
Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
[TBL] [Abstract][Full Text] [Related]
8. Will imaging assist in the selection of patients with heart failure for an ICD?
Gerson MC; Abdallah M; Muth JN; Costea AI
JACC Cardiovasc Imaging; 2010 Jan; 3(1):101-10. PubMed ID: 20129539
[TBL] [Abstract][Full Text] [Related]
9. Can antiarrhythmic drugs survive survival trials?
Pratt CM; Waldo AL; Camm AJ
Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
[TBL] [Abstract][Full Text] [Related]
10. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
Peck KY; Lim YZ; Hopper I; Krum H
Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
[TBL] [Abstract][Full Text] [Related]
11. Heart failure as a substrate and trigger for ventricular tachycardia.
Alvarez CK; Cronin E; Baker WL; Kluger J
J Interv Card Electrophysiol; 2019 Dec; 56(3):229-247. PubMed ID: 31598875
[TBL] [Abstract][Full Text] [Related]
12. Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.
Deniz HB; Ward A; Jaime Caro J; Alvarez P; Sadri H
Curr Med Res Opin; 2009 Mar; 25(3):617-26. PubMed ID: 19232036
[TBL] [Abstract][Full Text] [Related]
13. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
[TBL] [Abstract][Full Text] [Related]
14. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.
Anderson KP
J Interv Card Electrophysiol; 2005 Nov; 14(2):71-8. PubMed ID: 16374553
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillators: expanding indications and technologies.
Goldberger Z; Lampert R
JAMA; 2006 Feb; 295(7):809-18. PubMed ID: 16478904
[TBL] [Abstract][Full Text] [Related]
16. Current challenges in sudden cardiac death prevention.
Corrado D; Zorzi A; Vanoli E; Gronda E
Heart Fail Rev; 2020 Jan; 25(1):99-106. PubMed ID: 31346843
[TBL] [Abstract][Full Text] [Related]
17. [Primary prevention of sudden cardiac death implanted cardioverter defibrillator (ICD) versus antiarrhythmic drugs].
Iturralde Torres P
Arch Cardiol Mex; 2007; 77 Suppl 4():S4-129-32. PubMed ID: 18938711
[TBL] [Abstract][Full Text] [Related]
18. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
Grimm W
Card Electrophysiol Rev; 2003 Dec; 7(4):463-7. PubMed ID: 15071276
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
